Global Computer-Aided Drug Discovery Market Outlook and Impact due to COVID-19

Post COVID-19 Impact on Computer-Aided Drug Discovery Market

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues.

Research Dive' group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following:

o Long-term and short-term impact of Covid-19 on the market

o Cascading impact of Covid-19 on Computer-Aided Drug Discovery Market, due to the impact on its extended ecosystem

o Understanding the market behaviour Pre- and Post-COVID-19 pandemic

o Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity
We'll help you fight this crisis through our business intelligence solutions.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/159

Pre COVID-19 Analysis on Computer-Aided Drug Discovery Market

There is no deficit of antibiotic drugs in the market and these drugs have customarilybeenused for a much longer time compared to most of the other drugs. However, from time unknown humans have been fighting an unseen war with strange viruses and bacteria which is never going to end.
This, in some way or other, is contributing to the rise of antibiotics drug resistance which leads to the need for new antibiotics.

The research institutes segment held the largest market value in 2018 accounting for $602.3 billion and is expected to reach $1,873.4 billion by 2026 @ https://www.researchdive.com/purchase-enquiry/159

The computer-aided drug design (CADD) is amalgamated with wet-lab techniques to clarify the mechanism of drug resistance, to search for new antibiotic targets and to design new and original antibiotics for both existing and new targets. CADD process can produce an atomic level structure-activity relationship (SAR) which is used to facilitate the drug design process thuscurtailingboth time and costs.

The Ligand-based drug design segment held the largest market share in 2018, with a size of $606.9billion, and will further reach $1,878.2billion by 2026, at a CAGR of 15.2% @ https://www.researchdive.com/download-sample/159

Computer-Aided Drug Discovery Market Segmentation by Therapeutic Area

o Oncology
o Neurology
o Cardiovascular Disease
o Respiratory Disease
o Diabetes
o Others

Factors impacting the market

It is the significant rise in the availability of information and data related to small molecule and biological macromoleculethat has enhanced the efficiency of computer-aided drug discovery. This extensive resource has been applied to almost every phase in the drug discovery process and manufacturing activities such as validation, lead discovery, detecting targets, and optimization and preclinical tests. In recent years, successive developments have been observed in the computer-aided drug discovery techniques. These techniques includede novo design,molecular similarity calculation, molecular docking,pharmacophore modeling and mapping, and sequence-based virtual screening.

In addition, the increasing healthcare expenditure across the globe is another factor enhancing the growth of the global market of computer-aided drug discovery. Someother factors fueling the market include the rising demand to diminish healthcare expenses, affordable and good-quality drugs, frequent occurrence of several known and unknown diseases, positive results in ongoing clinical experimentations, increasing number of off-patented drugs, and growing claim for brand new medicines for cardiac and oncology disorders.

Computer-Aided Drug Discovery Market Segmentation by End-use

o Pharmaceutical Companies
o Biotechnology Companies
o Research Laboratories

Recent Developments in the Global Market
Key Players

o Schrodinger (NASDAQ: SDGR)
o Charles River (NYSE: CRL)
o AstraZeneca (LON: AZN)
o Evotec A.G. (ETR: EVT)
o Bayers AG (ETR: BAYN)
o BOC Sciences
o Aris Pharmaceuticals
o Aragen Bioscience
o Albany Molecular Research Inc. (AMRI)
o BioDuro

Get Access to Full Report (TOC, Figures, Chart, etc.) @ https://www.researchdive.com/159/computer-aided-drug-discovery-market

These market players are adopting several strategies including new technology, new product launches, current technology upgradation, and merger and acquisition to gain highest employee communication software market size.
Recently, a virtual reality (VR) platform developed by researchers at the University of Bristol has permitted the computational scientists, chemists, and structural biologists to collaboratively design molecules. "It's bringing human intuition to bear in a new way," asserts Adrian Mulholland, a professor in the Centre for Computational Chemistry of the University of Bristol.

Contact us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1-888-961-4454
E-mail: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521
Blog: https://www.researchdive.com/blog
Follow us: https://marketinsightinformation.blogspot.com/

About Us:
Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

This release was published on openPR.